Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, acne, rosacea, and psoriasis; and central nervous system, cardiovascular, and gastrointestinal diseases. Its strategic brands include ACTIKERALL, BALNEUM, DECODERM, SATIVEX, SKILARENCE, and DECODERM. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone34 93 291 30 00
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Almirall (OTCMKTS:LBTSF) Frequently Asked Questions
What is Almirall's stock symbol?
Almirall trades on the OTCMKTS under the ticker symbol "LBTSF."
What is the consensus analysts' recommendation for Almirall?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Almirall in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Almirall.
Has Almirall been receiving favorable news coverage?
Headlines about LBTSF stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Almirall earned a daily sentiment score of 1.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future. View News Stories for Almirall.
Who are some of Almirall's key competitors?
Some companies that are related to Almirall include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM), China Longyi Group Int'l (CGYG), Creative Medical Technology (CELZ), Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (CYCCP) and Eastgate Biotech (ETBI).
What other stocks do shareholders of Almirall own?
Who are Almirall's key executives?
Almirall's management team includes the folowing people:
- Mr. Jorge Gallardo Ballart, Chairman & Pres (Age 62)
- Mr. Peter Guenter, CEO, Chairman of Management Board & Exec. Director (Age 56)
- Mr. David Nieto, CFO, Exec. VP of Fin. & Member of Management Board
- Mr. Joan Figueras Carreras, Gen. Counsel, Corp. Director, Vice Sec., Member of Mgmt. Board & Non-Voting Director
- Mr. Eloi Crespo Cervera, VP of Manufacturing & Technical Services and Member of Management Board
How do I buy shares of Almirall?
Shares of LBTSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Almirall's stock price today?
One share of LBTSF stock can currently be purchased for approximately $17.03.
What is Almirall's official website?
How can I contact Almirall?
The company can be reached via phone at 34 93 291 30 00.
MarketBeat Community Rating for Almirall (OTCMKTS LBTSF)
MarketBeat's community ratings are surveys of what our community members think about Almirall and other stocks. Vote "Outperform" if you believe LBTSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LBTSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
